Please use this identifier to cite or link to this item:
Title: Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study
Authors: Albert Liu
David V. Glidden
Peter L. Anderson
K. Rivet Amico
Vanessa McMahan
Megha Mehrotra
Javier R. Lama
John MacRae
Juan Carlos Hinojosa
Orlando Montoya
Valdilea G. Veloso
Mauro Schechter
Esper G. Kallas
Suwat Chariyalerstak
Linda Gail Bekker
Kenneth Mayer
Susan Buchbinder
Robert Grant
Keywords: Medicine
Issue Date: 1-Jan-2014
Abstract: Copyright © 2014 by Lippincott Williams & Wilkins. Background: Adherence to pre-exposure prophylaxis (PrEP) is critical for efficacy. Antiretroviral concentrations are an objective measure of PrEP use and correlate with efficacy. Understanding patterns and correlates of drug detection can identify populations at risk for non-adherence and inform design of PrEP adherence interventions. Methods: Blood antiretroviral concentrations were assessed among active arm participants in iPrEx, a randomized placebo-controlled trial of emtricitabine/tenofovir in men who have sex with men and transgender women in 6 countries. We evaluated rates and correlates of drug detection among a random sample of 470 participants at week 8 and a longitudinal cohort of 303 participants through 72 weeks of follow-up. Results: Overall, 55% of participants (95% confidence interval: 49 to 60) tested at week 8 had drug detected. Drug detection was associated with older age and varied by study site. In longitudinal analysis, 31% never had drug detected, 30% always had drug detected, and 39% had an inconsistent pattern. Overall detection rates declined over time. Drug detection at some or all visits was associated with older age, indices of sexual risk, including condomless receptive anal sex, and responding "don't know" to a question about belief of PrEP efficacy (0-10 scale). Conclusions: Distinct patterns of study product use were identified, with a significant proportion demonstrating no drug detection at any visit. Research literacy may explain greater drug detection among populations having greater research experience, such as older men who have sex with men in the United States. Greater drug detection among those reporting highest risk sexual practices is expected to increase the impact and cost-effectiveness of PrEP.
ISSN: 10779450
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.